Leveraging Chimeric Antigen Receptor-T Cell Therapy for the Treatment of Multiple Sclerosis: Bridging Oncology and Neurology

Current Research in Translational Medicine · Published 2026-07-01 · DOI 10.1016/j.retram.2026.103603

Authors (8)

Matlyuba Sanoyeva, Nargiza Nasirdinova, Munisakhon Gulova, Nargiza Ortikova, Alexey Yumashev, Ro'zibek Tolmasov, Turgunbay Kholdarov, Zhanna R. Gardanova

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Sanoyeva, M., Nasirdinova, N., Gulova, M., et al. (2026). Leveraging Chimeric Antigen Receptor-T Cell Therapy for the Treatment of Multiple Sclerosis: Bridging Oncology and Neurology. Current Research in Translational Medicine. https://doi.org/10.1016/j.retram.2026.103603

Related articles

• Could adherence to SAMPL Guidelines improve statistical reporting in clinical manuscripts? Insights from 150 editorial reviews for specialty journals · Current Research in Translational Medicine · 2025 · Same journal
• Establishing hemoglobin A, F, A2 reference intervals in neonatal cord blood and clinical decision values for β-thalassemia genetic testing · Current Research in Translational Medicine · 2026 · Same journal
• Allogeneic hematopoietic stem cell transplantation in 18 patients with atypical inherited bone marrow failure syndromes: Efficacy and long-term outcomes · Current Research in Translational Medicine · 2025 · Same journal
• Organ transplantation in Africa: Confronting socioeconomic, cultural, and infrastructural hurdles · Current Research in Translational Medicine · 2025 · Same journal
• Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS syndrome management · Current Research in Translational Medicine · 2025 · Same journal
• Multidimensional evaluation of CMV-specific T Cells: enhancing therapy through transcriptional insights · Current Research in Translational Medicine · 2025 · Same journal
• Harnessing Dendritic Cells (DCs) for Melanoma Immunotherapy: From Basic Biology to Clinical Strategies · Current Research in Translational Medicine · 2026 · Same journal
• A survey on artificial intelligence use for myeloma and lymphoma management · Current Research in Translational Medicine · 2026 · Same journal
• Causal association between helicobacter pylori and lymphoma · Current Research in Translational Medicine · 2026 · Same journal
• Explainable AI for Parkinson’s disease prediction: A machine learning approach with interpretable models · Current Research in Translational Medicine · 2025 · Same journal